Effects of oncoplastic breast-conserving surgery on the psychological status, quality of life and survival prognosis of patients with early-stage breast cancer

To explore the effect of oncoplastic breast-conserving surgery (OBCS) on the psychological status, quality of life (QoL) and survival prognosis of patients with early breast cancer (BC). In this study, one hundred BC patients with early breast cancer were divided into two groups according to the random number table method. They were treated with traditional breast conserving surgery (BCS) and OBCS. The results showed that compared with the traditional BCS treatment group, the operation time of OBCS treatment group was significantly longer, while the intraoperative blood loss, postoperative drainage and hospital stay were significantly shorter; in terms of cosmetic effect, the excellent and good rate of OBCS (92.00%) was significantly higher than that of traditional BCS (74.00%); the Hamilton Anxiety Rating (HAMA) and Hamilton Depression Rating (HAMD) scores of patients in the postoperative OBCS were significantly lower than those in the traditional BCS; the scores of all items in the OBCS were significantly higher than those in the traditional breast conserving surgery treatment group; the total complication rate of OBCS was significantly lower than that of traditional BCS; within 1 year of follow-up, there was no significant difference in the recurrence rate and metastasis rate between the two groups (p > 0.05). It can be seen that compared with BCS, OBCS has better cosmetic effect, improves the poor psychological state of patients, improves the quality of life of patients, and has fewer complications.

Breast cancer; Traditional breast conserving surgery; Oncoplastic breast conserving surgery; Psychological state; Quality of life

[1] Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. British Journal of Hospital Medicine. 2022; 83: 1–7.

[2] Houghton SC, Hankinson SE. Hankinson, Cancer progress and priorities: breast cancer. Cancer Epidemiology, Biomarkers & Prevention. 2021; 30: 822–844.

[3] Sarhangi N, Hajjari S, Heydari SF, Ganjizadeh M, Rouhollah F, Hasanzad M. Breast cancer in the era of precision medicine. Molecular Biology Reports. 2022; 49: 10023–10037.

[4] Trayes KP, Cokenakes SEH. Breast cancer treatment. American Family Physician. 2021; 104: 171–178.

[5] Britt KL, Cuzick J, Phillips KA. Phillips, Key steps for effective breast cancer prevention. Nature reviews. Cancer. 2020; 20: 417–436.

[6] Schaverien MV, Kuerer HM, Caudle AS, Smith BD, Hwang RF, Robb GL. Outcomes of volume replacement oncoplastic breast-conserving surgery using chest wall perforator flaps: comparison with volume displacement oncoplastic surgery and total breast reconstruction. Plastic and Reconstructive Surgery. 2020; 146: 14–27.

[7] Kadam SS, Tripathi P, Jagtap R, Kapoor R, Kadam T, Bhandarkar P, Shimpi S. Modified radical mastectomy vs breast-conserving surgery: current clinical practice in women with early stage breast cancer at a corporate tertiary cancer center in India. Indian Journal of Surgical Oncology. 2022; 13: 322–328.

[8] Pak LM, Matar-Ujvary R, Verdial FC, Haglich KA, Sevilimedu V, Nelson JA, et al. ASO visual abstract: long-term patient-reported outcomes comparing oncoplastic breast surgery and conventional breast-conserving surgery-a propensity score-matched analysis. Annals of Surgical Oncology. 2023; 30: 7150–7151.

[9] Oei SL, Thronicke A, Grieb G, Schad F, Groß J. Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data. Breast Cancer. 2023; 30: 1008–1017.

[10] Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, et al. Panelists of the St Gallen consensus conference. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen international consensus guidelines for treatment of early breast cancer 2021. Annals of Oncology. 2021; 32: 1216–1235.

[11] Prabhu N, McGuire C, Hong P, Bezuhly M. Patient safety initiatives in cosmetic breast surgery: a systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2022; 75: 4180–4190.

[12] Goel N, Hernandez AE, Ream M, Clarke ES, Blomberg BB, Cole S, et al. Effects of neighborhood disadvantage on cortisol and interviewer-rated anxiety symptoms in breast cancer patients initiating treatment. Breast Cancer Research and Treatment. 2023; 202: 203–211.

[13] Liu P, Li P, Li Q, Yan H, Shi X, Liu C, et al. Effect of pretreatment of S-Ketamine on postoperative depression for breast cancer patients. Journal of Investigative Surgery. 2021; 34: 883–888.

[14] Md Yusof K, Mahmud R, Abdullah M, Avery-Kiejda KA, Rosli R. Cross-cultural adaptation of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Malaysian breast cancer survivors. Asian Pacific Journal of Cancer Prevention. 2021; 22: 1055–1061.

[15] El Masri J, Phadke S. Breast cancer epidemiology and contemporary breast cancer care: a review of the literature and clinical applications. Clinical Obstetrics and Gynecology. 2022; 65: 461–481.

[16] Grabinski VF, Brawley OW. Disparities in breast cancer. Obstetrics and Gynecology Clinics of North America. 2022; 49: 149–165.

[17] Desai P, Aggarwal A. Breast cancer in women over 65 years—a review of screening and treatment options. Clinics in Geriatric Medicine. 2021; 37: 611–623.

[18] Baker BG, Chadwick S, Patel N, Jeevan R. Comparative UK Cross-sectional study of breast cancer patient-reported outcomes for breast-conserving surgery and immediate reconstruction, including contribution to an international collaborative pilot study. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2022; 75: 2172–2179.

[19] Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, et al. Retrospective, multicenter analysis comparing conventional with oncoplastic breast conserving surgery: oncological and surgical outcomes in women with high-risk breast cancer from the OPBC-01/iTOP2 study. Annals of Surgical Oncology. 2022; 29: 1061–1070.

[20] De la Cruz Ku G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, Jonczyk M, Príncipe-Meneses FS, et al. Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients. Annals of Surgical Oncology. 2022; 29: 6163–6188.

[21] Jin S, Xu B, Shan M, Liu Y, Han J, Zhang G. Clinical significance of oncoplastic breast-conserving surgery and application of volume-displacement technique. Annals of Plastic Surgery. 2021; 86: 233–236.

[22] Tenna S, Morelli Coppola M, Salzillo R, Barone M, Brunetti B, Cagli B, et al. Delayed mastopexy following breast-conserving surgery and radiation therapy: a case-control study to evaluate safety and versatility of the central mound technique. Aesthetic Plastic Surgery. 2022; 46: 2164–2173.

[23] St Denis-Katz H, Ghaedi BB, Fitzpatrick A, Zhang J. Oncological safety, surgical outcome, and patient satisfaction of oncoplastic breast-conserving surgery with contralateral balancing reduction mammoplasty. Plastic Surgery. 2021; 29: 235–242.

[24] Zwakman M, Tan A, Boersma C, Klinkenbijl JHG, Noorda EM, de Jong TR, et al. Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancer. European journal of Surgical Oncology. 2022; 48: 1692–1698.

[25] Oh MY, Kim Y, Kim J, Cheun JH, Jung JG, Kim HK, et al. Comparison of long-term oncological outcomes in oncoplastic breast surgery and conventional breast-conserving surgery for breast cancer: a propensity score-matched analysis. Journal of Breast Cancer. 2021; 24: 520–530.

[26] Li H, Wang Y, Yang D, Petit JY, Ren G. Clinical study of the feasibility, complications, and cosmetic outcomes of immediate autologous fat grafting during breast-conserving surgery for early-stage breast cancer in China. Gland Surgery. 2021; 10: 2386–2397.

[27] Pak LM, Matar-Ujvary R, Verdial FC, Haglich KA, Sevilimedu V, Nelson JA, et al. Long-term patient-reported outcomes comparing oncoplastic breast surgery and conventional breast-conserving surgery: a propensity score-matched analysis. Annals of Surgical Oncology. 2023; 30: 7091–7098.

[28] Hauerslev KR, Overgaard J, Damsgaard TE, Hvid HM, Balling E, Fischer L, et al. Oncoplastic breast surgery versus conventional breast conserving surgery—a prospective follow-up study of subjective loco-regional late morbidity. Acta Oncologica. 2021; 60: 750–759.

[29] Maliko N, Schok T, Bijker N, Wouters MWJM, Strobbe LJA, Hoornweg MJ, et al. Oncoplastic breast conserving surgery: is there a need for standardization? Results of a nationwide survey. Breast Care. 2023; 18: 90–96.

[30] Tokui R, Ishitobi M, Kurita T, Hatano T, Maekawa M, Kusama H, et al. A comparison of the oncological outcomes after breast-conserving surgery with or without latissimus dorsi myocutaneous flap reconstruction for breast cancer. Clinical Breast Cancer. 2022; 22: e184–e190.